Showing results (1981-1990 of 2,112) with videos related to

Sort By:
Pageof 212
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|August 6, 2005
Longitudinal clinical and serological survey of abdominal angiostrongyliasis in Guaporé, southern Brazil, from 1995 to 1999Carlos Graeff-Teixeira, Aline Hamilton Goulart, Charles de Ornellas Brum, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
A metabolic constraint in the kynurenine pathway drives mucosal inflammation in IBDLina Welz, Danielle Mm Harris, Na-Mi Kim, et al.
Journal of Medicinal Chemistry|December 2, 2022
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast DifferentiationJana Flegel, Saad Shaaban, Zhi Jun Jia, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Pageof 212